News

18

Jun, 2019

Penta website – take our survey!

Tags:

Penta has recently restyled its website and we’d really like to find out how you feel about it and what contents you want to read here. This will help us make improvements to our online communication and prioritize new features. The survey only takes 5 minutes, and your responses are completely anonymous.

READ MORE

18

Jun, 2019

Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries.

 

Authors: Hsia Y, Lee BR, Versporten A, et al; GARPEC and Global-PPS networks. Published in: Lancet Glob Health. 2019;7(7):e861-e871 Background Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally. We aimed to present data on patterns of paediatric AWaRe antibiotic use that could be used for local and national stewardship interventions. Methods 1-day point prevalence survey antibiotic prescription data were combined from two independent global networks: the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children and the Global Point Prevalence Survey on Antimicrobial […]

READ MORE

5

Jun, 2019

Hard to study, hard to treat: putting children at the centre of antibiotic research and development

 

Authors: Balasegaram M, Pécoul B, Gray G, Sharland M, Swaminathan S. Published in: Lancet Infect Dis. 2019;19(6):573-574 Abstract Newborn babies, infants, and children are substantially affected by antimicrobial resistance. Globally, infectious diseases remain a major cause of morbidity and mortality in children, and an estimated 214 000 newborn babies died from drug-resistant bacterial infections in 2015

READ MORE
NEWSLETTER

We would like to update you on our recent activities